Literature DB >> 2966237

Hexosaminidase A deficiency presenting as juvenile progressive dystonia.

R J Hardie, E P Young, J A Morgan-Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966237      PMCID: PMC1032879          DOI: 10.1136/jnnp.51.3.446

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients.

Authors:  E M Brett; R B Ellis; L Haas; J U Ikonne; B D Lake; A D Patrick; R Stephens
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

2.  Juvenile GM2-gangliosidosis. Clinical variant of Tay-Sachs disease or a new disease.

Authors:  K Suzuki; I Rapin; Y Suzuki; N Ishii
Journal:  Neurology       Date:  1970-02       Impact factor: 9.910

3.  Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype.

Authors:  W G Johnson; H J Wigger; H R Karp; L M Glaubiger; L P Rowland
Journal:  Ann Neurol       Date:  1982-01       Impact factor: 10.422

4.  Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis.

Authors:  D Meek; L S Wolfe; E Andermann; F Andermann
Journal:  Ann Neurol       Date:  1984-04       Impact factor: 10.422

5.  Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.

Authors:  Z Argov; R Navon
Journal:  Ann Neurol       Date:  1984-07       Impact factor: 10.422

6.  The clinical spectrum of hexosaminidase deficiency diseases.

Authors:  W G Johnson
Journal:  Neurology       Date:  1981-11       Impact factor: 9.910

7.  Hexosaminidase-A deficiency presenting as atypical juvenile-onset spinal muscular atrophy.

Authors:  S Parnes; G Karpati; S Carpenter; N M Kin; L S Wolfe; L Suranyi
Journal:  Arch Neurol       Date:  1985-12

8.  Adult onset supranuclear ophthalmoplegia, cerebellar ataxia, and neurogenic proximal muscle weakness in a brother and sister: another hexosaminidase A deficiency syndrome.

Authors:  A E Harding; E P Young; F Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

9.  A new juvenile hexosaminidase deficiency disease presenting as cerebellar ataxia. Clinical and biochemical studies.

Authors:  W G Johnson; A Chutorian; A Miranda
Journal:  Neurology       Date:  1977-11       Impact factor: 9.910

  9 in total
  6 in total

Review 1.  Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation.

Authors:  R G Gray; M A Preece; S H Green; W Whitehouse; J Winer; A Green
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

2.  An adult onset hexosaminidase A deficiency syndrome with sensory neuropathy and internuclear ophthalmoplegia.

Authors:  D Barnes; V P Misra; E P Young; P K Thomas; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

Review 3.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

4.  Neurodegeneration with Progressive Dystonia: Juvenile-Onset Tay-Sachs Disease.

Authors:  Jasmine Kaur; Singanamalla Bhanudeep; Ramprabhu G Suresh; Arushi G Saini; Vikas Bhatia
Journal:  Ann Indian Acad Neurol       Date:  2022-05-17       Impact factor: 1.714

5.  Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease).

Authors:  H Schnorf; R Gitzelmann; N U Bosshard; M Spycher; W Waespe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

6.  An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist.

Authors:  Rita Christopher; Bindu P Sankaran
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.